Ahold Delhaize Agrees to Pay $40 Million to Resolve Allegations of Inflated Prescription Drug Pricing
A discount program is supposed to lower the price of a prescription. The dispute at the center of a newly announced $40 million settlement is what happens when those discounts exist for customers but are not reflected in the prices reported to government healthcare programs.
